HCPCS Q5001–Q5171 codes: Temporary codes
This range contains 80 HCPCS Level II codes in the 2026 CMS fee schedule data. Select a code to see its full RVU breakdown, Medicare status and related codes.
- HCPCS Q5001 — Hospice or home hlth in home
- HCPCS Q5002 — Hospice/home hlth in asst lv
- HCPCS Q5003 — Hospice in lt/non-skilled nf
- HCPCS Q5004 — Hospice in snf
- HCPCS Q5005 — Hospice, inpatient hospital
- HCPCS Q5006 — Hospice in hospice facility
- HCPCS Q5007 — Hospice in ltch
- HCPCS Q5008 — Hospice in inpatient psych
- HCPCS Q5009 — Hospice/home hlth, place nos
- HCPCS Q5010 — Hospice home care in hospice
- HCPCS Q5098 — Inj ustekinumab-srlf, 1 mg
- HCPCS Q5099 — Inj ustekinumab-stba, 1 mg
- HCPCS Q5100 — Inj ustekinumab-kfce, 1 mg
- HCPCS Q5101 — Injection, zarxio
- HCPCS Q5103 — Injection, inflectra
- HCPCS Q5104 — Injection, renflexis
- HCPCS Q5105 — Inj retacrit esrd on dialysi
- HCPCS Q5106 — Inj retacrit non-esrd use
- HCPCS Q5107 — Inj mvasi 10 mg
- HCPCS Q5108 — Injection, fulphila
- HCPCS Q5109 — Injection, ixifi, 10 mg
- HCPCS Q5110 — Nivestym
- HCPCS Q5111 — Injection, udenyca 0.5 mg
- HCPCS Q5112 — Inj ontruzant 10 mg
- HCPCS Q5113 — Inj herzuma 10 mg
- HCPCS Q5114 — Inj ogivri 10 mg
- HCPCS Q5115 — Inj truxima 10 mg
- HCPCS Q5116 — Inj., trazimera, 10 mg
- HCPCS Q5117 — Inj., kanjinti, 10 mg
- HCPCS Q5118 — Inj., zirabev, 10 mg
- HCPCS Q5119 — Inj ruxience, 10 mg
- HCPCS Q5120 — Inj pegfilgrastim-bmez 0.5mg
- HCPCS Q5121 — Inj. avsola, 10 mg
- HCPCS Q5122 — Inj, nyvepria
- HCPCS Q5123 — Inj. riabni, 10 mg
- HCPCS Q5124 — Inj. byooviz, 0.1 mg
- HCPCS Q5125 — Inj, releuko 1 mcg
- HCPCS Q5126 — Inj alymsys 10 mg
- HCPCS Q5127 — Inj, stimufend, 0.5 mg
- HCPCS Q5128 — Inj, cimerli, 0.1 mg
- HCPCS Q5129 — Inj, vegzelma, 10 mg
- HCPCS Q5130 — Inj, fylnetra, 0.5 mg
- HCPCS Q5133 — Inj, tofidence, 1 mg
- HCPCS Q5134 — Inj, tyruko, 1 mg
- HCPCS Q5135 — Inj, tyenne, 1 mg
- HCPCS Q5136 — Inj. denosumab-bbdz, 1 mg
- HCPCS Q5137 — Inj, wezlana, sub cu, 1 mg
- HCPCS Q5138 — Inj, wezlana, iv, 1 mg
- HCPCS Q5139 — Inj, eculizumab-aeeb, 10 mg
- HCPCS Q5140 — Inj adalimumab-fkjp, 1 mg
- HCPCS Q5141 — Inj adalimumab-aaty, 1 mg
- HCPCS Q5142 — Inj adalimumab-ryvk, 1 mg
- HCPCS Q5143 — Inj adalimumab-adbm, 1 mg
- HCPCS Q5144 — Inj, idacio, 1 mg
- HCPCS Q5145 — Inj, abrilada, 1 mg
- HCPCS Q5146 — Inj, hercessi, 10 mg
- HCPCS Q5147 — Inj, aflibercept-ayyh, 1 mg
- HCPCS Q5148 — Inj, nyposi 1 mcg
- HCPCS Q5149 — Inj, aflibercept-abzv, 1 mg
- HCPCS Q5150 — Inj, aflibercept-mrbb, 1 mg
- HCPCS Q5151 — Inj, eculizumab-aagh, 2 mg
- HCPCS Q5152 — Inj, eculizumab-aeeb, 2 mg
- HCPCS Q5153 — Inj, aflibercept-yszy, 1 mg
- HCPCS Q5154 — Inj, omlyclo, 5 mg
- HCPCS Q5155 — Inj, aflibercept-jbvf, 1 mg
- HCPCS Q5156 — Inj, tocilizumab-anoh, 1 mg
- HCPCS Q5157 — Inj, denosumab-bmwo, 1 mg
- HCPCS Q5158 — Inj, denosumab-bnht, 1 mg
- HCPCS Q5159 — Inj, denosumab-dssb, 1 mg
- HCPCS Q5160 — Inj, jobevne, 10 mg
- HCPCS Q5161 — Inj, denosumab-kyqq, 1 mg
- HCPCS Q5162 — Inj, denosumab-nxxp, 1 mg
- HCPCS Q5164 — Ustekinumab-hmny, 1 mg
- HCPCS Q5165 — Inj, denosumab-mobz, 1 mg
- HCPCS Q5166 — Inj, denosumab-desu, 1 mg
- HCPCS Q5167 — Inj, denosumab-qbde, 1 mg
- HCPCS Q5168 — Inj. nufymco, 0.1 mg
- HCPCS Q5169 — Inj, armlupeg, 0.5 mg
- HCPCS Q5170 — Inj, aflibercept-boav, 1 mg
- HCPCS Q5171 — Inj, den (boncres), bio, 1mg